China Universal Asset Management Co., Ltd. Biocryst Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $700 Million
- Q2 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 24,247 shares of BCRX stock, worth $178,942. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,247
Previous 39,639
38.83%
Holding current value
$178,942
Previous $201,000
25.87%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding BCRX
# of Institutions
257Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$147 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$139 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$92.8 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$69 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$65.1 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.37B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...